Insulin Glargine (Lantus) from Japan
Insulin glargine is a long-acting basal insulin analogue produced by recombinant DNA technology, modified for a prolonged release profile. As a derivative and structural analogue of insulin used primarily as a hormone, it is classified under tariff item 2937.12.00.
Duty Rate — Japan → Canada
0%
Import Tips
• Provide documentation that the product is a structural analogue of insulin, including the amino acid modifications
• Import as bulk API to avoid classification under pharmaceutical headings
• Ensure compliance with Canadian regulations for biologic drugs